FIPNet


18
Jun 10

PhysioGenix Releases Free Online Study Design Tool

Milwaukee, WI (PRWEB) June 17, 2010 — PhysioGenix, Inc. - http://www.physiogenix.com – a leading preclinical CRO, has launched a free web application to aide the study design, planning, and execution. The online tool will allow researchers to hand pick different aspects of a study, from endpoints, assays, tissue samples, and more. PhysioGenix is currently looking for beta users to try out the newly built tool. Feel free to visit http://physiogenix.com/sign-up to register to use this free study design tool and provide feedback.

The study design tool is aimed at gathering vital information for a preclinical rodent study in a matter of minutes. Traditionally within the industry, gathering this information could take weeks of planning, phone calls, and emails. Now with this new study design tool, planning can be completed online in a matter of minutes. Researchers are free to use the tool as much as they would like. Throughout the process, PhysioGenix can be called upon for expertise in designing your specific preclinical study. PhysioGenix has the network of experts, that combined with the study design tool, can help make the planning stages easier, and faster. Continue reading →


25
Mar 10

PhysioGenix Wins Company to Watch for 2010

PhysioGenix was announced a winner of Company to Watch for 2010. The award is made by the Wisconsin Entrepreneur Network (WEN) with support from the Wisconsin Department of Commerce and the Division of Entrepreneurship and Economic Development at the University of Wisconsin-Extension in association with the Edward Lowe Foundation to celebrate second-stage entrepreneurial companies. Chief Executive Officer Dr. Brian Curry stated, “We are deeply honored to be named as a company to watch in 2010.” Over the past two years the company has under went a major business and scientific reorganization, so the PhysioGenix team views the award as external validation of the progress that has been made. With the new PhysioGenix vision to improve the quality of life through biopharmaceutical solutions by providing preventative, curative and palliative interventions for chronic diseases; the company is excited by the future. Continue reading →


11
Feb 10

Outsourcing: Cloud Computing and Data Security

With the proliferation of many web based applications, blogs, social media sites, media sharing sites, and web-collaboration tools, much of today’s data resides on web servers. With this data architecture, information, materials, and media can be accessed from anywhere in the world with an internet connection. Data can be gathered on demand, with limited usage and storage on hardware and software at the local level. This allows access from multiple people, and does not require everyone to have that piece of data on their personal computer. Can you imagine if everyone downloaded every YouTube video that was watched? There would be massive redundancy on everyones computer, but with cloud computing, every YouTube video simply resides on YouTube’s servers, and can be accessed from their website. While cloud computing has become a business success, it is important to address the information security concerns.

Continue reading →


29
Jan 10

FIPNet Supported by Cloud Computing

My colleague Brian discussed the FIPNet model in his last post as a structure for drug development and as a model for allocating “core” and “non-core” competencies among various partners to assure that your business has best practices throughout the entire drug development lifecycle.

Today, I would like to talk about how “cloud computing” has accelerated and facilitated the viability of the FIPNet model.  If you have used Facebook, Linkedin, Salesforce, Google Apps. or other similar tools on the Internet, then you have used cloud computing.  “Cloud computing” in its broadest sense refers to the delivery of applications over the internet, which are accessed via a web browser; the data and software resides on remote servers.  At PhysioGenix, we have worked over the last year to move our IT infrastructure into the “cloud”.  This has created greater efficiencies, dramatically reduced costs and increased our delivery time of information to our clients.

Continue reading →


22
Jan 10

Outsourcing: FIPNet becomes a Core Competency

As my colleague Greg discussed last week, Eli Lilly, like many other large pharmaceutical companies, has realized the importance of strategic partnerships from discovery to launch. Current market forces and outdated operating dynamics have forced large pharmaceutical companies to investigate “fully integrated pharmaceutical network” (FIPNets) as a way to gain best practices in non-core competencies. And while the pharmaceutical industry continues to determine the precise nature of an efficient FIPNet model, there is no doubt that strategic partnerships will play an ever-increasing role in drug development.

Continue reading →